Groups information

Group name

Xi

Groups remarks

Match 3

BCR
Continence

Continence

9 (9–11)

p-value

1

remark

Median (IQR) postoperative urethral catheterization (Day)

Sexual Function
PSA

PSA

36/40 (90.0%)

p-value

1

remark

90-day undetectable PSA rate

Complications or other prognosis

Complications or other prognosis

5/40 (12.5%)

p-value

1

remark

Major complications (CL-D > 3)

Positive surgical margin (PSM)

PSM

21/40 (52.5%)

p-value

1

remark

Positive surgical margins

Other quality of life
Surgical related outcomes

Surgical Related Outcomes

9.0 (7.5–16.0)

p-value

1

remark

Median lymph node yield (IQR)

Survival Outcome
Survival Outcome
Other outcomes
Follow Up Time

Follow Up Time

90 DAY